Literature DB >> 2689184

The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.

J Wilson1, M M Wahbha, P G Martin, R Hainsworth, A M Brownjohn, J H Turney, J A Davies, C R Prentice.   

Abstract

The effect of nisoldipine on renal function after 6 weeks treatment was investigated in hypertensive patients with and without renal impairment. Nisoldipine was well tolerated and an effective antihypertensive agent when administered over a period of 6 weeks. There were no significant changes in glomerular filtration, cardiac output, plasma renin activity or serum biochemistry during nisoldipine administration. Effective renal plasma flow was unaffected by treatment in the patients with normal renal function, but in the patients with renal insufficiency, the value decreased by a mean of 12%. Nisoldipine had no major untoward effects on renal function after 6 weeks administration, but minor changes in renal haemodynamics in the patients with renal insufficiency would suggest that careful monitoring of renal function is indicated in such patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689184     DOI: 10.1007/bf00558120

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Cardiovascular responses to upright tilting in healthy subjects.

Authors:  R Hainsworth; Y M Al-Shamma
Journal:  Clin Sci (Lond)       Date:  1988-01       Impact factor: 6.124

2.  Renal effects of nicardipine in essential hypertension: differences between acute and chronic therapy.

Authors:  S A Smith; E I Rafiqi; E G Gardener; M A Young; W A Littler
Journal:  J Hypertens       Date:  1987-12       Impact factor: 4.844

3.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.

Authors:  J Menard; K J Catt
Journal:  Endocrinology       Date:  1972-02       Impact factor: 4.736

4.  Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.

Authors:  W Kiowski; O Bertel; P Erne; P Bolli; U L Hulthén; R Ritz; F R Bühler
Journal:  Hypertension       Date:  1983 Mar-Apr       Impact factor: 10.190

5.  The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.

Authors:  P A Meredith; F Pasanisi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

6.  Altered pressor responses in long-term nitrendipine treatment.

Authors:  G Simon; D K Snyder
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

7.  Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).

Authors:  S Kazda; B Garthoff; H Meyer; K Schlossmann; K Stoepel; R Towart; W Vater; E Wehinger
Journal:  Arzneimittelforschung       Date:  1980

8.  Clinical effects of intravenous nifedipine on renal function.

Authors:  S Yokoyama; T Kaburagi
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

9.  A modified single breath method for estimation of cardiac output in humans at rest and during exercise.

Authors:  Y M Al-Shamma; R Hainsworth; N P Silverton
Journal:  Clin Sci (Lond)       Date:  1987-04       Impact factor: 6.124

10.  Pharmacokinetics of nisoldipine in renal dysfunction.

Authors:  J Boelaert; Y Valcke; H Dammekens; G De Vriese; G Ahr; M Schurgers; R Daneels; M G Bogaert
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  3 in total

Review 1.  Influence of antihypertensive therapy on renal function.

Authors:  U Frei; R Schindler; K M Koch
Journal:  Clin Investig       Date:  1992

2.  Cardiovascular responses to upright tilting in hypertensive patients, with and without renal impairment and before and following nisoldipine treatment.

Authors:  M M Wahbha; J Wilson; R Hainsworth
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 3.  Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.